Skip Navigation


Human Molecular Genetics Advance Access originally published online on February 2, 2005
Human Molecular Genetics 2005 14(6):799-811; doi:10.1093/hmg/ddi074
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
14/6/799    most recent
ddi074v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Greene, J. C.
Right arrow Articles by Pallanck, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greene, J. C.
Right arrow Articles by Pallanck, L. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions{at}oupjournals.org

Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis

Jessica C. Greene, Alexander J. Whitworth, Laurie A. Andrews, Tracey J. Parker and Leo J. Pallanck*

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA

* To whom correspondence should be addressed. Tel: +1 2066165997; Fax: +1 2065430754; Email: pallanck{at}gs.washington.edu

Received December 3, 2004; Accepted January 18, 2005

Loss-of-function mutations of the parkin gene, which encodes a ubiquitin-protein ligase, are a common cause of autosomal recessive juvenile parkinsonism (ARJP). Previous work has led to the identification of a number of Parkin substrates that implicate specific pathways in ARJP pathogenesis, including endoplasmic reticulum (ER) stress and cell cycle activation. To test the involvement of previously implicated pathways, as well as to identify novel pathways in ARJP pathogenesis, we are using genetic and genomic approaches to study Parkin function in the fruit fly Drosophila melanogaster. In previous work, we demonstrated that Drosophila parkin null mutants exhibit mitochondrial pathology and flight muscle degeneration. To further explore the mechanisms responsible for pathology in parkin mutants, we analyzed the transcriptional alterations that occur during muscle degeneration and performed a genetic screen for parkin modifiers. Results of these studies indicate that oxidative stress response components are induced in parkin mutants and that loss-of-function mutations in oxidative stress components enhance the parkin mutant phenotypes. Genes involved in the innate immune response are also induced in parkin mutants. In contrast, our studies did not reveal evidence for cell cycle or ER stress pathway induction in parkin mutants. These results suggest that oxidative stress and/or inflammation may play a fundamental role in the etiology of ARJP.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
M. E. Haque, K. J. Thomas, C. D'Souza, S. Callaghan, T. Kitada, R. S. Slack, P. Fraser, M. R. Cookson, A. Tandon, and D. S. Park
Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP
PNAS, February 5, 2008; 105(5): 1716 - 1721.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. C. Poole, R. E. Thomas, L. A. Andrews, H. M. McBride, A. J. Whitworth, and L. J. Pallanck
The PINK1/Parkin pathway regulates mitochondrial morphology
PNAS, February 5, 2008; 105(5): 1638 - 1643.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
W. Mandemakers, V. A. Morais, and B. De Strooper
A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases
J. Cell Sci., May 15, 2007; 120(10): 1707 - 1716.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. M. Rosen, V. Veereshwarayya, C. E-H. Moussa, Q. Fu, M. S. Goldberg, M. G. Schlossmacher, J. Shen, and H. W. Querfurth
Parkin Protects against Mitochondrial Toxins and beta-Amyloid Accumulation in Skeletal Muscle Cells
J. Biol. Chem., May 5, 2006; 281(18): 12809 - 12816.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Jiang, Q. Jiang, W. Liu, and J. Feng
Parkin Suppresses the Expression of Monoamine Oxidases
J. Biol. Chem., March 31, 2006; 281(13): 8591 - 8599.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. J. Whitworth, D. A. Theodore, J. C. Greene, H. Benes, P. D. Wes, and L. J. Pallanck
Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease
PNAS, May 31, 2005; 102(22): 8024 - 8029.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.